Recent Company News

• 04:16 AM ET Jul 18, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:13 AM ET Jul 18, 2025
  

  BioGaia reports Q2 EPS SEK0.87 vs FactSet SEK0.93 [3 est, SEK0.82-1.00] (SEK 108.00, 0.00)

• 04:07 AM ET Jul 16, 2025
  

  BioGaia launches a subsidiary company, BioGaia New Sciences; appoints Maik Lepatey to head new subsidiary (SEK 108.30, +0.90)

• 03:36 AM ET Jun 26, 2025
  

  BioGaia upgraded to buy from hold at SEB (pre-open) (SEK 100.90, +3.30)

• 06:55 AM ET Jun 03, 2025
  

  StreetAccount Summary - European unusual volume traders

• 01:59 PM ET Mar 28, 2025
  

  Infant Bacterial Therapeutics announces FDA has granted Breakthrough Therapy designation for IBP-9414's potential to reduce gastrointestinal-related mortality (SEK 37.30, 0.00)

• 06:01 AM ET Mar 26, 2025
  

  BioGaia releases sustainability report (SEK 109.00, -2.70)

• 04:49 PM ET Mar 20, 2025
  

  BioGaia discloses Anatom Holding becomes anchor shareholder (SEK 116.50, 0.00)